These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes? Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945 [TBL] [Abstract][Full Text] [Related]
28. Surgical strategy for local recurrence after resection of rectal cancer. Fujii S; Shimada H; Yamagishi S; Ota M; Ichikawa Y; Kunisaki C; Ike H; Ohki S Hepatogastroenterology; 2009; 56(91-92):667-71. PubMed ID: 19621677 [TBL] [Abstract][Full Text] [Related]
30. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199 [TBL] [Abstract][Full Text] [Related]
31. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694 [TBL] [Abstract][Full Text] [Related]
32. French current management and oncological results of locally recurrent rectal cancer. Denost Q; Faucheron JL; Lefevre JH; Panis Y; Cotte E; Rouanet P; Jafari M; Capdepont M; Rullier E; Eur J Surg Oncol; 2015 Dec; 41(12):1645-52. PubMed ID: 26482348 [TBL] [Abstract][Full Text] [Related]
34. Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer. Bhangu A; Brown G; Akmal M; Tekkis P Br J Surg; 2012 Oct; 99(10):1453-61. PubMed ID: 22961529 [TBL] [Abstract][Full Text] [Related]
36. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer. Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111 [TBL] [Abstract][Full Text] [Related]
37. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years. Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581 [TBL] [Abstract][Full Text] [Related]
38. Effect of Surgery on Health-Related Quality of Life of Patients With Locally Recurrent Rectal Cancer. Pellino G; Sciaudone G; Candilio G; Selvaggi F Dis Colon Rectum; 2015 Aug; 58(8):753-61. PubMed ID: 26163954 [TBL] [Abstract][Full Text] [Related]
39. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design. Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252 [TBL] [Abstract][Full Text] [Related]
40. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent. Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]